Long Term Safety Study of NVA237 vs QAB149 in COPD Patients

Clinical trial NCT01697696 · COMPLETED

Trial details

NCT number: NCT01697696
Sponsor: Novartis Pharmaceuticals
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Chronic Obstructive Pulmonary Disease (COPD)

Start date: 2012-10-01
Primary completion: 2014-11-01
Enrollment: 511

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.